Evaluating vaccines for HIV using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates
Funded at University of Louisiana at Lafayette · NIH-10817646 · Data updated 2026-11-12
This study is looking at how well potential AIDS vaccines work by testing them on nonhuman primates, which helps researchers find effective ways to prevent or control HIV infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2023 |
| Award (this year) | $115,505 |
| NIH project number | 75N93020D00008-P00004-759302000002-1 |
| Project ID | NIH-10817646 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals at high risk for HIV who may eventually receive effective vaccines developed through these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to vaccination programs may not receive direct benefits from this research.
What this research studies
This research focuses on the use of nonhuman primates (NHPs) to evaluate candidate AIDS vaccines and prevention strategies. By maintaining and studying these animals, researchers can conduct thorough assessments of immune responses and vaccine efficacy. The program aims to identify effective vaccines that can generate immune responses capable of preventing or controlling HIV infection. This work supports all stages of AIDS vaccine research, from preclinical evaluations to clinical testing.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection.
How similar studies have gone: Previous research using nonhuman primates for vaccine evaluation has shown promise, indicating that this approach is supported by prior successes.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.